LFM
BSX icon

LGT Fund Management’s Boston Scientific BSX Stock Holding History

LGT Fund Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.02M Buy
95,955
+36,611
+62% +$2.93M 0.26% 86
2025
Q4 		$5.7M Buy
59,344
+5,070
+9% +$497K 0.45% 51
2025
Q3 		$5.2M Buy
54,274
+1,808
+3% +$187K 0.42% 52
2025
Q2 		$5.64M Sell
52,466
-5,838
-10% -$591K 0.49% 47
2025
Q1 		$5.88M Buy
58,304
+54,139
+1,300% +$5.45M 0.53% 49
2024
Q4 		$372K Hold
4,165
– – 0.03% 208
2024
Q3 		$352K Buy
4,165
+164
+4% +$12.9K 0.04% 177
2024
Q2 		$308K Buy
+4,001
New +$293K 0.04% 171

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LGT Fund Management's BSX Position: Q1 2026 in Review

LGT Fund Management increased its Boston Scientific (BSX) stake by 62% in Q1 2026, buying an estimated $2.93M and bringing the position to 95,955 shares worth $6.02M. The position accounts for 0.26% of the portfolio, ranked #86.

LGT Fund Management first reported a position in BSX in Q2 2024 and has held it in 8 quarters since. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • LGT Fund Management held 95,955 shares of Boston Scientific worth $6.02M as of Q1 2026.
  • LGT Fund Management bought 36,611 Boston Scientific shares in Q1 2026, an estimated $2.93M.
  • Boston Scientific made up 0.26% of LGT Fund Management's portfolio in Q1 2026, its #86 holding.
  • LGT Fund Management first reported a position in Boston Scientific in Q2 2024 and has held it in 8 quarters since.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on LGT Fund Management's 13F filing for Q1 2026, filed 28 Apr 2026.